Literature DB >> 7978861

Molecular pharmacology of somatostatin-receptor subtypes.

C Bruns1, G Weckbecker, F Raulf, K Kaupmann, P Schoeffter, D Hoyer, H Lübbert.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7978861     DOI： 10.1111/j.1749-6632.1994.tb17263.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  29 in total

Review 1.  The therapeutic value of somatostatin and its analogues.

Authors:  S Farooqi; J S Bevan; M C Sheppard; J A Wass
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin.

Authors:  A Nagy; A V Schally; G Halmos; P Armatis; R Z Cai; V Csernus; M Kovács; M Koppán; K Szepesházi; Z Kahán
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 3.  Cardiothoracic manifestations of neuroendocrine tumours.

Authors:  Ramin Mandegaran; Sarojini David; Nicholas Screaton
Journal:  Br J Radiol       Date:  2016-01-19       Impact factor: 3.039

Review 4.  Advances in the therapy of gastroenteropancreatic-neuroendocrine tumours (GEP-NETs).

Authors:  Enrique Grande; Juan José Díez; Vanessa Pachón; Alfredo Carrato
Journal:  Clin Transl Oncol       Date:  2010-07       Impact factor: 3.405

Review 5.  Pharmacotherapy or surgery as primary treatment for acromegaly?

Authors:  D Ferone; A Colao; A J van der Lely; S W Lamberts
Journal:  Drugs Aging       Date:  2000-08       Impact factor: 3.923

6.  Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients.

Authors:  Lucia Anna Muscarella; Vito D'Alessandro; Annamaria la Torre; Massimiliano Copetti; Angelo De Cata; Paola Parrella; Marco Sperandeo; Fabio Pellegrini; Vincenzo Frusciante; Evaristo Maiello; Giuseppe Merla; Vito Michele Fazio; Gianluigi Vendemiale
Journal:  Cell Oncol (Dordr)       Date:  2011-04-19       Impact factor: 6.730

7.  Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Authors:  M John; W Meyerhof; D Richter; B Waser; J C Schaer; H Scherübl; J Boese-Landgraf; P Neuhaus; C Ziske; K Mölling; E O Riecken; J C Reubi; B Wiedenmann
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

8.  Expression of somatostatin and somatostatin receptor subtypes 1-5 in human normal and diseased kidney.

Authors:  Sunil Bhandari; Neil Watson; Ervine Long; Steve Sharpe; Wenwen Zhong; Shang-Zhong Xu; Stephen L Atkin
Journal:  J Histochem Cytochem       Date:  2008-04-28       Impact factor: 2.479

9.  Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues.

Authors:  S Jonas; M John; J Boese-Landgraf; R Häring; G Prevost; F Thomas; S Rosewicz; E O Riecken; B Wiedenmann; P Neuhaus
Journal:  Langenbecks Arch Chir       Date:  1995

10.  Comparative distribution of somatostatin and somatostatin receptors in PTU-induced hypothyroidism.

Authors:  Sneha Singh; Rishi K Somvanshi; Vandana Panda; Ujendra Kumar
Journal:  Endocrine       Date:  2020-04-25       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.